# Claudio Ponticelli

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/claudio-ponticelli-2/

## Facts

| Field | Value |
| --- | --- |
| Citations | 25,305 |
| Field | Renal Diseases and Glomerulopathies |
| h-index | 82 |
| i10-index | 341 |
| OpenAlex ID | https://openalex.org/A5073365136 |
| Works | 708 |

## Researcher papers

- [Effect of the Angiotensin-Converting–Enzyme Inhibitor Benazepril on the Progression of Chronic Renal Insufficiency](https://scholariq.org/papers/effect-of-the-angiotensin-converting-enzyme-inhibitor-benazepril-on-the/)
- [Discovery of new risk loci for IgA nephropathy implicates genes involved in immunity against intestinal pathogens](https://scholariq.org/papers/discovery-of-new-risk-loci-for-iga-nephropathy-implicates-genes-involved-in/)
- [Genome-wide association study identifies susceptibility loci for IgA nephropathy](https://scholariq.org/papers/genome-wide-association-study-identifies-susceptibility-loci-for-iga-nephropathy/)
- [Hydroxychloroquine in systemic lupus erythematosus (SLE)](https://scholariq.org/papers/hydroxychloroquine-in-systemic-lupus-erythematosus-sle/)
- [“Nephritic flares” are predictors of bad long-term renal outcome in lupus nephritis](https://scholariq.org/papers/nephritic-flares-are-predictors-of-bad-long-term-renal-outcome-in-lupus/)
- [Rituximab or Cyclophosphamide in the Treatment of Membranous Nephropathy: The RI-CYCLO Randomized Trial](https://scholariq.org/papers/rituximab-or-cyclophosphamide-in-the-treatment-of-membranous-nephropathy-the-ri/)
- [Validation of a predictive model of idiopathic membranous nephropathy: Its clinical and research implications](https://scholariq.org/papers/validation-of-a-predictive-model-of-idiopathic-membranous-nephropathy-its/)
- [Hyperuricemia as a trigger of immune response in hypertension and chronic kidney disease](https://scholariq.org/papers/hyperuricemia-as-a-trigger-of-immune-response-in-hypertension-and-chronic-kidney/)
- [Genome-wide association analyses define pathogenic signaling pathways and prioritize drug targets for IgA nephropathy](https://scholariq.org/papers/genome-wide-association-analyses-define-pathogenic-signaling-pathways-and/)

## Researcher topics

- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)
- [Renal Transplantation Outcomes and Treatments](https://scholariq.org/topics/renal-transplantation-outcomes-and-treatments/)
- [Systemic Lupus Erythematosus Research](https://scholariq.org/topics/systemic-lupus-erythematosus-research/)
- [Neurological Complications and Syndromes](https://scholariq.org/topics/neurological-complications-and-syndromes/)
- [Organ Transplantation Techniques and Outcomes](https://scholariq.org/topics/organ-transplantation-techniques-and-outcomes/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.